FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 167 filers reported holding FIBROGEN INC in Q3 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,392,014 | -75.4% | 1,613,181 | -23.2% | 0.00% | -76.5% |
| Q2 2023 | $5,670,000 | -94.0% | 2,100,000 | -58.2% | 0.02% | -94.1% |
| Q1 2023 | $93,793,128 | -6.8% | 5,026,427 | -20.0% | 0.29% | -15.2% |
| Q4 2022 | $100,631,953 | +23.2% | 6,281,645 | +0.1% | 0.34% | +4.9% |
| Q3 2022 | $81,673,000 | +17.8% | 6,277,700 | -4.4% | 0.33% | +11.3% |
| Q2 2022 | $69,340,000 | -1.1% | 6,566,292 | +12.6% | 0.29% | +5.4% |
| Q1 2022 | $70,103,000 | +33.2% | 5,832,161 | +56.2% | 0.28% | +32.4% |
| Q4 2021 | $52,630,000 | +363.5% | 3,732,594 | +235.9% | 0.21% | +320.0% |
| Q3 2021 | $11,355,000 | – | 1,111,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |